Skip to main content
. 2016 May 6;11(5):e0154851. doi: 10.1371/journal.pone.0154851

Fig 4. Effects of MrgC agonist and anti-MrgC on nociceptive behaviors in BCP mice.

Fig 4

BCP mice were administered with BAM8-22 or anti-MrgC for 7 consecutive days (starting from day 14 after operation), and then the nociceptive behaviors were assessed at days 0, 1, 3, and 7 (Day 0-Day 7) after drug administration. Statistical analyses of NSF (A) and PWMT (B) in BCP mice treated with BAM8-22 or anti-MrgC. Compared with BCP model controls at corresponding time point, & P < 0.05.